Brooktree Capital Management Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Brooktree Capital Management grew its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 3.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,604 shares of the medical instruments supplier’s stock after buying an additional 139 shares during the period. West Pharmaceutical Services accounts for 1.1% of Brooktree Capital Management’s investment portfolio, making the stock its 20th largest position. Brooktree Capital Management’s holdings in West Pharmaceutical Services were worth $1,382,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Empowered Funds LLC raised its holdings in West Pharmaceutical Services by 68.1% during the 1st quarter. Empowered Funds LLC now owns 1,585 shares of the medical instruments supplier’s stock valued at $627,000 after acquiring an additional 642 shares during the period. Avantax Advisory Services Inc. lifted its holdings in West Pharmaceutical Services by 11.0% during the 1st quarter. Avantax Advisory Services Inc. now owns 907 shares of the medical instruments supplier’s stock worth $359,000 after purchasing an additional 90 shares in the last quarter. Bleakley Financial Group LLC lifted its holdings in West Pharmaceutical Services by 1.9% during the 1st quarter. Bleakley Financial Group LLC now owns 2,174 shares of the medical instruments supplier’s stock worth $860,000 after purchasing an additional 41 shares in the last quarter. State Board of Administration of Florida Retirement System boosted its stake in West Pharmaceutical Services by 2.5% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 86,901 shares of the medical instruments supplier’s stock worth $34,388,000 after purchasing an additional 2,105 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in West Pharmaceutical Services by 22.7% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 105,998 shares of the medical instruments supplier’s stock valued at $41,944,000 after buying an additional 19,626 shares in the last quarter. Institutional investors own 93.90% of the company’s stock.

West Pharmaceutical Services Trading Up 5.1 %

Shares of WST opened at $344.12 on Thursday. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70. The stock has a market cap of $24.92 billion, a PE ratio of 51.06, a P/E/G ratio of 24.78 and a beta of 1.00. The company has a quick ratio of 2.23, a current ratio of 3.00 and a debt-to-equity ratio of 0.07. The business’s 50-day moving average price is $304.87 and its 200-day moving average price is $316.60.

West Pharmaceutical Services (NYSE:WST) last posted its earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.50 by $0.35. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The business had revenue of $746.90 million for the quarter, compared to analyst estimates of $709.62 million. During the same quarter in the prior year, the firm posted $2.16 EPS. West Pharmaceutical Services’s revenue was down .1% on a year-over-year basis. On average, equities analysts forecast that West Pharmaceutical Services, Inc. will post 6.66 EPS for the current fiscal year.

West Pharmaceutical Services Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 20th. Investors of record on Wednesday, November 13th will be given a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.24%. The ex-dividend date of this dividend is Wednesday, November 13th. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.20. West Pharmaceutical Services’s dividend payout ratio (DPR) is 11.87%.

Insider Activity at West Pharmaceutical Services

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 1,029 shares of the company’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $300.00, for a total value of $308,700.00. Following the transaction, the vice president now directly owns 1,478 shares in the company, valued at $443,400. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.53% of the stock is owned by corporate insiders.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.